David J VanderWeele Gladell P Paner Gini F Fleming Russell Z Szmulewitz
10.3389/fonc.2015.00169
Front Oncol
2015 Jul 22;5:169.
brca2 erg parp inhibitor tp53 complete response prostate cancer veliparib
CC BY
https://pubmed.ncbi.nlm.nih.gov/26258074/
PMC4510409
26258074
Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer - A Case Report
2015